Digital therapeutics (DTx), the use of software-based interventions to prevent and treat disease, is one of the biggest areas of growth in life sciences. CB Insights reported that 2021 funding in the digital health industry grew 79% over 2020,1 and the global DTx market is projected to hit $13.1 billion by 2026, up from $3.4 billion in 2021.2 Many say digital therapeutics will rewrite the future of healthcare. While it sounds aspirational, the DTx industry isn’t just “pie in the sky.” Studies show improved outcomes from digital therapeutics...
Read the full article, including quotes from our co-founder & Chief Medical Officer, Dr. Michael Aratow, here.